Evidence map›Paper›PMID 26740626›Full record

ArticleThe Journal of biological chemistry2016

Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor.

Maoqing Dong, Polo C-H Lam, Andrew Orry, Patrick M Sexton, Arthur Christopoulos, Ruben Abagyan, Laurence J Miller

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Capturing Peptide-GPCR Interactions and Their Dynamics.Molecules (Basel, Switzerland) · 2020
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Maoqing DongFrom the Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Scottsdale, Arizona 85259.
Polo C-H LamMolsoft LLC, La Jolla, California 92037.
Andrew OrryMolsoft LLC, La Jolla, California 92037.
Patrick M SextonDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville 3052, Australia, and.
Arthur ChristopoulosDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville 3052, Australia, and.
Ruben AbagyanMolsoft LLC, La Jolla, California 92037, the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92037.
Laurence J MillerFrom the Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Scottsdale, Arizona 85259, miller@mayo.edu.
Mayo Clinic in Arizona · USMolsoft (United States) · USMonash University · AUUniversity of Montana · US

Funding

SECRETIN RECEPTOR STRUCTURE, FUNCTION, AND REGULATIONR01DK046577 · NIDDK · MAYO CLINIC COLL OF MED, MAYO CLINIC AZ · PI MILLER, LAURENCE J · 1995 to 2013
$4.9M
Macromolecular DockingR01GM071872 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ABAGYAN, RUBEN · 2004 to 2017
$4.2M
Secretin Receptor Structure, Function and RegulationR56DK046577 · NIDDK · MAYO CLINIC ARIZONA · PI MILLER, LAURENCE J · 2014 to 2014
$154k
NIDDK NIH HHS DK046577NIDDK NIH HHS R01 DK046577NIDDK NIH HHS R56 DK046577NIGMS NIH HHS R01 GM071872
6 · The paper itself

Abstract

Amino-terminal regions of secretin-family peptides contain key determinants for biological activity and binding specificity, although the nature of interactions with receptors is unclear. A helix N-capping motif within this region has been postulated to directly contribute to agonist activity while also stabilizing formation of a helix extending toward the peptide carboxyl terminus and docking within the receptor amino terminus. We used cysteine trapping to systematically explore spatial approximations between cysteines replacing each residue in this motif of secretin (sec), Phe(6), Thr(7), and Leu(10), and cysteines incorporated into the extracellular face of the receptor. Each peptide was a full agonist for cAMP, but had a lower binding affinity than natural hormone. These bound to COS cells expressing 61 receptor constructs incorporating cysteines in every position along each extracellular loop (ECL) and adjacent parts of transmembrane (TM) segments. Patterns of covalent labeling were distinct for each probe, with Cys(6)-sec labeling multiple residues in the carboxyl-terminal half of ECL2 and throughout ECL3, Cys(7)-sec predominantly labeling only single residues in the carboxyl-terminal end of ECL2 and the amino-terminal end of ECL3, and Cys(10)-sec not efficiently labeling any of these residues. These spatial constraints were used to refine our model of secretin bound to its receptor, now bringing ECL3 above the amino terminus of the ligand and revealing possible charge-charge interactions between this part of secretin and receptor residues in TM5, TM6, ECL2, and ECL3, which can orient and stabilize the peptide-receptor complex. This was validated by testing predicted approximations by mutagenesis and residue-residue complementation studies.

Indexed as

Amino Acid MotifsAmino Acid SequenceAnimalsBinding SitesChlorocebus aethiopsCHO CellsCOS CellsCricetinaeCricetulusCyclic AMPCysteineHumansMolecular Sequence DataProtein BindingReceptors, Gastrointestinal HormoneReceptors, G-Protein-CoupledCyclic AMPCysteineReceptors, Gastrointestinal HormoneReceptors, G-Protein-CoupledSecretinsecretin receptorcell surface receptorcyclic AMP (cAMP)gel electrophoresisG protein-coupled receptor (GPCR)ligand-binding proteinmembrane proteinmolecular modelingmutagenesispeptides

Identifiers

PMID26740626
PMCPMC4777851
OpenAlexW2237347256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.